Biomedical beauty group UltraV (CEO Dr. Han Jin Kwon) held an event commemorating the launch of PDO Microsphere powder filler 'UltraCol' at the Haikou Marriott Hotel in Hainan, China on March 2nd.

                This event is the first official event held since the product certification in Hainan Province, China last December, and was prepared to expand China's market share by supplying premium filler products to the Chinese cosmetic surgery market, which has recently been growing rapidly. 

Executives from Sinopharm, a large Chinese pharmaceutical company, executives from investment company TigerMed, top executives from local financial institutions, and government officials participated in the event to celebrate the company's successful entry into the Chinese market. 

CEO Kwon Han Jin promoted the technology of ‘UltraCol’ through Hainan and used this as an opportunity to advance into mainland China by accumulating experience and data on Chinese patients. “We will do our best to become a representative local product in the newly entering Chinese market,,” he said.

Meanwhile, medical staff and officials who attended the launching event on this day highly evaluated the product's safety, excellent effectiveness, and surgical know-how.

UltraV's Ultracol is a product that can be expected to provide volume and lifting effects by stimulating self-collagen production with microspheres made of PDO (polydioxanone).​